Britzilam binds SV2A with high affinity. SV2A is known to play a role in epileptogenesis through modulation of synaptic GABA release. It is thought that brivaracetam exerts its anti-epileptogenic effects through its binding to SV2A. Britzilam is also known to inhibit Na+ channels which may also contribute to its anti-epileptogenic action. The precise mechanism by which Britzilam exerts its anticonvulsant Activity is not known. Britzilam displays a high and selective affinity for synaptic vesicle protein 2A (SV2A) in the brain, which may contribute to the anticonvulsant effect.

Do not take Britzilam 25 Tablet 14's if you are known to be allergic to Britzilam 25 Tablet 14's. Inform your doctor if you have suicidal ideation or behaviour symptoms, drug addiction, chronic lung diseases, muscle weakness, heart problems, liver/kidney impairment. Do not stop taking Britzilam 25 Tablet 14's without consulting your doctor to avoid precipitating seizures. Avoid intake of Britzilam 25 Tablet 14's if you are pregnant or planning for pregnancy or nursing mothers unless prescribed by the doctor. Britzilam 25 Tablet 14's should not be given to children unless prescribed. Britzilam 25 Tablet 14's causes drowsiness and dizziness, so drive only if you are alert. Avoid consuming alcohol along with Britzilam 25 Tablet 14's as it could lead to increased dizziness and sleepiness. Taking Britzilam 25 Tablet 14's with opioids analgesics or pain killers like oxycodone can cause respiratory failure, coma, and even leading to death, so avoid its intake together. If you are taking any sleeping pills or tranquillizers, let your doctor know about this as Britzilam 25 Tablet 14's interacts with these drugs to cause sleepiness, drowsiness, and dizziness and affect your daily Activity. Britzilam 25 Tablet 14's contain lactose (a type of sugar), If you have an intolerance to some sugars, contact your doctor before taking Britzilam 25 Tablet 14's. Britzilam 25 Tablet 14's may be habit-forming. Misuse can cause addiction, overdose, or death.